Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease-Reference-Cited by-同舟云学术

Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease

Published:2016-10 Issue: Volume:253 Page:135-143
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Anguiano Lidia,Riera Marta^ORCID,Pascual Julio,Valdivielso José Manuel,Barrios Clara,Betriu Angels,Clotet Sergi,Mojal Sergi,Fernández Elvira,Soler María José^ORCID

Funder

AbbVie

Spanish government RETIC

ISCIII-FEDER

ISCIII RETIC REDINREN

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention;Sarnak;Hypertension,2003

2. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N. Engl. J. Med.,2004

3. Effect of pravastatin on cardiovascular events in people with chronic kidney disease;Tonelli;Circulation,2004

4. The value of carotid intima-media thickness for predicting cardiovascular risk;Simon;Arterioscler. Thromb. Vasc. Biol.,2010

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal denervation benefits in chronic kidney disease: An updated review;Yemen Journal of Medicine;2024-09-15

2. Prognostic value of elevated plasma angiotensin-converting enzyme 2 in cardiometabolic diseases: A review;Medicine;2023-03-10

3. Circulating angiotensin converting enzyme 2 and COVID-19;World Journal of Clinical Cases;2022-12-06

4. Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease;Journal of Personalized Medicine;2022-09-13

5. The Need for Individualized Risk Assessment in Cardiovascular Disease;Journal of Personalized Medicine;2022-07-14